Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Q4 Results Today: Colgate Pamolive, Eicher Motors, Hindalco, Sun Pharma, NTPC Green, Ircon And More — Check Estimates
The list of companies scheduled to report Q4 results on May 22 also includes 20 Microns, 3M India, Century Plyboards (India), DAM Capital Advisors, Electronics Mart India and more.
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?
Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady margin outlook despite higher R&D spending, with EBITDA growth supported by diversified global business momentum outlook
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Sohum Asset CIO sees 3-5% more market correction, says buy the dip
Sanjay Parekh, Founder & CIO of Sohum Asset Managers has shifted sharply towards large-cap market leaders, remains cautious on IT, turned positive on Sun Pharma and is selectively betting on renewables through Waaree Energies.
Indices open with major losses in early trade; breadth weak
Media, PSU Bank and realty shares declined while pharma and IT shares advanced.
Sun Pharma Share Price Live Updates: Sun Pharma's Trading Metrics
Mankind Pharma Q4 Result: Net Profit Rises 32%, Margins Expand
Consolidate revenue of Mankind Pharma advanced by 11.8% year-on-year for the three months ended March, reaching Rs 3,443 crore in comparison to Rs 3,079 crore.
Sun Pharma ARC partner gets USFDA setback on drug approval application
Sun Pharma Advanced Research Company says Ocuvex Therapeutics received a USFDA Complete Response Letter for PDP-716, shares fall on regulatory setback
Sun Pharma Advanced Research Company raises Rs 150 cr via warrant issuance
Each of the Warrant, so allotted, is convertible into or exchangeable for one fully paid-up equity share of face value of Re 1/- of the Company in accordance with the provisions of SEBI ICDR Regulations.
KPI Green Energy gains 5% after securing 120 MW BESS order from GUVNL
The stock advanced after KPI Green's subsidiary Sun Drops Energia executed a Battery Energy Storage Purchase Agreement (BESPA) with Gujarat Urja Vikas Nigam Limited (GUVNL)
Sun Pharma Advanced Research Company reports consolidated net profit of Rs 1761.34 crore in the March 2026 quarter
Sales decline 51.45% to Rs 13.20 crore
